Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis

References

• Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99
   PubMed Web of Science ®Google Scholar
• Berber E. Causes of hypothyroidism [Internet]. Montclair, NJ: EndocrineWeb; 2014 [cited March 9, 2018]. Available from: https://www.endocrineweb.com/conditions/hypothyroidism/causes-hypothyroidism. [Last accessed 13 November 2017]
   Google Scholar
• Ferrari SM, Fallahi P, Vita R, et al. Peroxisome proliferator-activated receptor-γ in thyroid autoimmunity. PPAR Res 2015;2015;232818
   PubMed Web of Science ®Google Scholar
• Klein I, Levey GS. Unusual manifestations of hypothyroidism. Arch Intern Med 1984;144:123-8
   PubMedGoogle Scholar
• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 2014;24:1670-751
   PubMed Web of Science ®Google Scholar
• El-Shafie KT. Clinical presentation of hypothyroidism. J Family Community Med 2003;10:55-8
   Google Scholar
• Bouchou K, André M, Cathébras P, et al. Thyroid disease and multiple autoimmune syndromes. Clinical and immunogenetic aspects apropos of 11 cases. Rev Med Intern 1995;16:283-7
   PubMed Web of Science ®Google Scholar
• Lazúrová I, Benhatchi K, Rovenský J, et al. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. Ann N Y Acad Sci 2009;1173:211-16
   PubMed Web of Science ®Google Scholar
• Lazúrová I, Benhatchi K. Autoimmune thyroid diseases and nonorgan-specific autoimmunity. Pol Arch Med Wewn 2012;122(Suppl 1):55-9
   PubMed Web of Science ®Google Scholar
• Giorda CB, Carnà P, Romeo F, et al. Prevalence, incidence and associated comorbidities of treated hypothyroidism: an update from a European population. Eur J Endocrinol 2017;176:533-42
   PubMed Web of Science ®Google Scholar
• Kasperlik-Zaluska A, Czarnocka B, Czech W. High prevalence of thyroid autoimmunity in idiopathic Addison’s disease. Autoimmunity 1994;18:213-16
   PubMed Web of Science ®Google Scholar
• Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab 2014;16:193-205
   PubMed Web of Science ®Google Scholar
• Thyroid hormone treatment [Internet]. Falls Church, VA: American Thyroid Association; 2017 [cited March 9, 2018]. Available from: https://www.thyroid.org/thyroid-hormone-treatment/ [Last accessed June 16, 2018]
   Google Scholar
• Center for Drug Evaluation and Research. Orange book: approved drug products with therapeutic equivalence evaluations, 37th ed. Rockville, MD: US Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Office of Generic Drugs; 2017
   Google Scholar
• Vita R, Fallahi P, Antonelli A, et al. The administration of L-thyroxine as soft gel capsule or liquid solution. Expert Opin Drug Deliv 2014;11:1103-11
   PubMed Web of Science ®Google Scholar
• Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988-1028
   PubMed Web of Science ®Google Scholar
• Scavone C, Sportiello L, Cimmaruta D, et al. Medication adherence and the use of new pharmaceutical formulations: the case of levothyroxine. Minerva Endocrinol 2016;41:279-89
   PubMed Web of Science ®Google Scholar
• Crilly M. Thyroxine adherence in primary hypothyroidism. Lancet 2004;363:1558
   PubMed Web of Science ®Google Scholar
• Pharmacy Quality Alliance. 2018 PQA medication quality measures in the health insurance marketplace [Internet]. Alexandria, VA: Pharmacy Quality Alliance; 2017 [cited March 9, 2018]. Available from: https://pqaalliance.org/measures/qrs.asp [Last accessed June 16, 2018]
   Google Scholar
• Medicare Part D quality measures [Internet]. Alexandria, VA: Academy of Managed Care Pharmacy; 2014 [cited March 9, 2018]. Available from: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=18900 [Last accessed June 16, 2018]
   Google Scholar
• Hanemaaijer S, Sodihardjo F, Horikx A, et al. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm 2015;37:1128-35
   PubMed Web of Science ®Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. Adherence to long-term therapies: evidence for action [Internet]. Geneva, Switzerland: World Health Organization; 2017 [cited March 9, 2018]. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf [Last accessed 13 November 2017]
   Google Scholar
• Mathes T, Pieper D, Antoine S-L, et al. 50% adherence of patients suffering chronic conditions–where is the evidence? Ger Med Sci 2012;10:Doc 16
   PubMedGoogle Scholar
• Briesacher BA, Andrade SE, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008;28:437-43
   PubMed Web of Science ®Google Scholar
• Crilly M, Esmail A. Randomised controlled trial of a hypothyroid educational booklet to improve thyroxine adherence. Br J Gen Pract 20015;55:362-8
   Google Scholar
• Carswell JM, Gordon JH, Popovsky E, et al. Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J Clin Endocrinol Metab 2013;98:610-17
   PubMed Web of Science ®Google Scholar
• Mayor GH, Orlando T, Kurtz NM. Limitations of Levothyroxine bioequivalence evaluation: analysis of an attempted study. Am J Ther 1994;2:417-32
   Google Scholar
• Håkonsen H, Eilertsen M, Borge H, et al. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin 2009;25:2515-21
   PubMed Web of Science ®Google Scholar
• Kesselheim AS, Misono AS, Shrank WH, et al. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med 2013;173:202-8
   PubMed Web of Science ®Google Scholar
• Sander JW, Ryvlin P, Stefan H, et al. Generic substitution of antiepileptic drugs. Expert Rev Neurother 2010;10:1887-98
   PubMed Web of Science ®Google Scholar
• Weissenfeld J, Stock S, Lüngen M, et al. The nocebo effect: a reason for patients’ non-adherence to generic substitution? Pharmazie 2010;65:451-6
   PubMed Web of Science ®Google Scholar
• Hypothyroidism symptom profiler [Internet]. North Chicago, IL: AbbVie Inc.; 2017 [cited March 9, 2018]. Available from: https://www.synthroid.com/support/hypothyroidism-resources [Last accessed 13 November 2017]
   Google Scholar
• Briesacher BA, Andrade SE, Fouayzi H, et al. Medication adherence and the use of generic drug therapies. Am J Manag Care 2009;15:450-6
   PubMed Web of Science ®Google Scholar